Inhaled drug formulation involves consideration of multiple factors, including the properties of the API, the needs of the target patient population, the delivery requirements, and the choice of ...

A global contract development and manufacturing organization focused on drug-device combination products. The company operates across multiple sites in the U.S. and the U.K., including a U.K.

Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions, today announced that it has manufactured Phase 2 clinical trial supplies for a dry powder inhalation (DPI) ...

Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has successfully dosed the ...

Please provide your email address to receive an email when new articles are posted on . The ICoN-1 trial has been discontinued, and futility was the reason for this decision. The company is still ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced the submission of a new drug application (NDA) to the ...